SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sudeep Pharma - Quaterly Results

07 Feb 2026 Evaluate
The revenue zoomed 8.15% to Rs. 902.82 millions for the quarter ended December 2025 as compared to Rs. 834.82 millions during the corresponding quarter last year.An average growth of 30.23% was recorded for the quarter ended December 2025 to Rs. 268.68  millions from Rs. 206.31 millions.OP of the company witnessed a marginal growth to 390.50 millions from 287.54 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202512 202412 % Var
Sales 902.82 834.82 8.15 902.82 834.82 8.15 902.82 834.82 8.15
Other Income 94.38 22.88 312.50 94.38 22.88 312.50 94.38 22.88 312.50
PBIDT 390.50 287.54 35.81 390.50 287.54 35.81 390.50 287.54 35.81
Interest 6.32 12.48 -49.36 6.32 12.48 -49.36 6.32 12.48 -49.36
PBDT 384.18 275.06 39.67 384.18 275.06 39.67 384.18 275.06 39.67
Depreciation 17.95 15.32 17.17 17.95 15.32 17.17 17.95 15.32 17.17
PBT 366.23 259.74 41.00 366.23 259.74 41.00 366.23 259.74 41.00
TAX 97.55 53.43 82.58 97.55 53.43 82.58 97.55 53.43 82.58
Deferred Tax 4.90 -0.48 -1120.83 4.90 -0.48 -1120.83 4.90 -0.48 -1120.83
PAT 268.68 206.31 30.23 268.68 206.31 30.23 268.68 206.31 30.23
Equity 112.95 97.23 16.17 112.95 97.23 16.17 112.95 97.23 16.17
PBIDTM(%) 43.25 34.44 25.58 43.25 34.44 25.58 43.25 34.44 25.58

Sudeep Pharma Share Price

610.30 -3.45 (-0.56%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×